Spinal fluid biobank aims to unlock secrets of rare childhood brain disorders

NCT ID NCT07313098

Not yet recruiting Knowledge-focused Sponsor: Imagine Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will collect and analyze cerebrospinal fluid from 1,000 children with various neurological conditions, such as traumatic brain injury or hydrocephalus. Researchers will look for protein markers that could help diagnose and track these diseases more accurately. The goal is to build a biobank that can be used for future research, especially for rare pediatric brain disorders where data is currently limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better diagnostic tools and biomarkers for rare neurological diseases in children, improving early detection and treatment monitoring.
What could go wrong: This is an observational study that does not test a treatment, so it will not directly benefit participants. The findings may not translate into clinical practice for years, if at all.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

central nervous system disorder nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CENTRAL NERVOUS SYSTEM DISEASES NEUROLOGIC DISORDER

Contacts and locations

Locations

Hôpital Necker-Enfants malades

Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.